We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XHE icon
951
State Street SPDR S&P Health Care Equipment ETF
XHE
$165M
$8.18M 0.01%
99,916
-3,727
-4% -$291K
VIS icon
952
Vanguard Industrials ETF
VIS
$8.48B
$8.17M 0.01%
56,055
-1,458
-3% -$208K
ALC icon
953
Alcon
ALC
$35B
$8.15M 0.01%
+131,980
New +$7.75M
TYG
954
Tortoise Energy Infrastructure Corp
TYG
$1.08B
$8.14M 0.01%
90,209
+29,755
+49% +$2.74M
VWOB icon
955
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.25B
$8.07M 0.01%
100,380
-353
-0.4% -$27.6K
DK icon
956
Delek US
DK
$3.58B
$8.07M 0.01%
199,093
+71,634
+56% +$2.62M
DNI
957
DELISTED
Dividend and Income Fund
DNI
$8.06M 0.01%
698,960
-148,606
-18% -$1.72M
IBN icon
958
ICICI Bank
IBN
$108B
$8.03M 0.01%
637,827
+7,306
+1% +$84.7K
DOCU
959
DocuSign
DOCU
$11.5B
$8.02M 0.01%
161,418
+13,609
+9% +$727K
AOS icon
960
A.O. Smith
AOS
$8.7B
$8.02M 0.01%
170,010
+11,453
+7% +$562K
FDT icon
961
First Trust Developed Markets ex-US AlphaDEX Fund
FDT
$1.31B
$7.97M 0.01%
147,802
+8,569
+6% +$459K
BNFT
962
DELISTED
Benefitfocus, Inc.
BNFT
$7.95M 0.01%
292,980
+30,468
+12% +$1.02M
CP icon
963
Canadian Pacific Kansas City
CP
$80.5B
$7.93M 0.01%
168,635
-80,820
-32% -$3.61M
ARW icon
964
Arrow Electronics
ARW
$10.4B
$7.92M 0.01%
111,190
-3,431
-3% -$253K
HI
965
DELISTED
Hillenbrand
HI
$7.91M 0.01%
199,890
+6,939
+4% +$279K
DVN icon
966
Devon Energy
DVN
$47.3B
$7.89M 0.01%
276,724
-78,991
-22% -$2.35M
MOS icon
967
The Mosaic Company
MOS
$7.33B
$7.86M 0.01%
314,020
-48,726
-13% -$1.19M
EXAS
968
DELISTED
Exact Sciences
EXAS
$7.86M 0.01%
66,545
+1,919
+3% +$193K
SNX icon
969
TD Synnex
SNX
$20.2B
$7.83M 0.01%
159,106
+27,864
+21% +$1.38M
EPAM icon
970
EPAM Systems
EPAM
$5.03B
$7.82M 0.01%
45,191
+7,714
+21% +$1.33M
VGK icon
971
Vanguard FTSE Europe ETF
VGK
$31.1B
$7.82M 0.01%
142,440
-4,413
-3% -$240K
VCR icon
972
Vanguard Consumer Discretionary ETF
VCR
$6.18B
$7.82M 0.01%
43,585
-1,127
-3% -$199K
TECD
973
DELISTED
Tech Data Corp
TECD
$7.82M 0.01%
74,727
-4,333
-5% -$440K
UNF icon
974
Unifirst Corp
UNF
$5.25B
$7.81M 0.01%
41,421
+176
+0.4% +$28.5K
WORK
975
DELISTED
Slack Technologies, Inc.
WORK
$7.81M 0.01%
+208,187
New +$7.67M

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.